Ticker brief
EPRX EUPRAXIA PHARMACEUTICALS INC
Consumer, Non-cyclical · Biotechnology
last close
$6.67
1 day
-9.4%
14 days
-0.7%
mkt cap
·
signals 14d
5
authors 14d
2
crowd 14d
+0.53
Sentiment — last 14 days
daily mean sentiment, 2026-08-19 → 2026-08-26 · now +0.60 (−1 bearish … +1 bullish)
Who spoke2
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Gantosj | B | +2.48 | 3 | +0.58 |
| @VistaPResearch | C | · | 2 | +0.28 |
Recent signals5of 5 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-26 | @Gantosj | +0.60 | Expects another leg higher after consolidation above a channel breakout and the 200DMA. | -10.2% | tweet ↗ |
| 2026-08-25 | @Gantosj | +0.50 | Says momentum reflects expectations for Q4 data supported by earlier Phase 2a results. | -10.1% | tweet ↗ |
| 2026-08-24 | @VistaPResearch | +0.30 | Describes EPRX pursuing a precise treatment for eosinophilic esophagitis. | -8.4% | tweet ↗ |
| 2026-08-24 | @Gantosj | +0.65 | EPRX broke its downtrend channel and 200-day average with positive momentum. | -8.4% | tweet ↗ |
| 2026-08-19 | @VistaPResearch | +0.25 | Bullish biotech theme built around Moderna and Merck melanoma momentum. | -4.9% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.